Lebovits Chaim 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Lebovits Chaim
President & CEO
Transactions
- Award
Common Stock
2024-05-28$0.52/sh+15,000$7,775→ 1,164,865 total
Holdings
- 2,000,847(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $0.5161 to $0.5194, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.